- Home
- PRAX vs HIFS Comparison
PRAX vs HIFS Comparison
Compare PRAX & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- HIFS
- Stock Information
- Founded
- PRAX 2015
- HIFS 1834
- Country
- PRAX United States
- HIFS United States
- Employees
- PRAX N/A
- HIFS N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- HIFS Major Banks
- Sector
- PRAX Health Care
- HIFS Finance
- Exchange
- PRAX Nasdaq
- HIFS Nasdaq
- Market Cap
- PRAX 599.7M
- HIFS 581.6M
- IPO Year
- PRAX 2020
- HIFS N/A
- Fundamental
- Price
- PRAX $46.32
- HIFS $275.21
- Analyst Decision
- PRAX Strong Buy
- HIFS
- Analyst Count
- PRAX 11
- HIFS 0
- Target Price
- PRAX $114.73
- HIFS N/A
- AVG Volume (30 Days)
- PRAX 299.7K
- HIFS 89.1K
- Earning Date
- PRAX 08-12-2025
- HIFS 07-11-2025
- Dividend Yield
- PRAX N/A
- HIFS 0.96%
- EPS Growth
- PRAX N/A
- HIFS 14.93
- EPS
- PRAX N/A
- HIFS 12.96
- Revenue
- PRAX $8,122,000.00
- HIFS $67,590,000.00
- Revenue This Year
- PRAX N/A
- HIFS N/A
- Revenue Next Year
- PRAX $6,358.50
- HIFS N/A
- P/E Ratio
- PRAX N/A
- HIFS $20.17
- Revenue Growth
- PRAX 270.02
- HIFS 12.43
- 52 Week Low
- PRAX $26.70
- HIFS $174.39
- 52 Week High
- PRAX $91.83
- HIFS $300.00
- Technical
- Relative Strength Index (RSI)
- PRAX 63.87
- HIFS 73.54
- Support Level
- PRAX $40.93
- HIFS $245.75
- Resistance Level
- PRAX $44.40
- HIFS $236.74
- Average True Range (ATR)
- PRAX 2.26
- HIFS 6.77
- MACD
- PRAX -0.08
- HIFS 5.25
- Stochastic Oscillator
- PRAX 95.12
- HIFS 98.02
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.